- $513.97m
- $524.75m
- $927.34m
- 74
- 71
- 87
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 812 | 778 | 816 | 848 | 927 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 754 | 713 | 785 | 851 | 922 |
Operating Profit | 58.4 | 64.5 | 31.2 | -3.02 | 5.68 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 57.1 | 63.3 | 30.3 | -3.64 | 5.06 |
Provision for Income Taxes | |||||
Net Income After Taxes | 47.2 | 52.8 | 25.3 | -1.96 | 4.43 |
Net Income Before Extraordinary Items | |||||
Net Income | 47.2 | 52.8 | 25.3 | -1.96 | 4.43 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 47.2 | 52.8 | 25.3 | -1.96 | 4.43 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.64 | 1.79 | 0.812 | -0.061 | 0.134 |
Dividends per Share |